In the mammalian CNS, aspartate and glutamate are major excitatory amino ac
ids, and their receptors are believed to mediate a wide range of physiologi
cal and pathological processes, including neurotransmission, plasticity, ex
citotoxicity, and Various forms of neurodegeneration. The immediate early g
ene pip92 has been identified in serum-stimulated BALB/c 3T3 fibroblasts, a
ctivated T lymphocytes treated with cycloheximide, and fibroblast growth fa
ctor-stimulated hippocampal cells during neuronal differentiation. In this
study we have demonstrated that pip92 is expressed in the mouse brain after
a single intraperitoneal injection of NMDA. The distribution of pip92 mRNA
levels in the NMDA-treated mouse brain was investigated using in situ RT-P
CR. The region-specific activation of pip92 in the CNS was observed 3 h aft
er NMDA injection, and high levels of pip92 mRNA were detected in the hippo
campal dentate gyrus and piriform cortex regions. In addition, the activati
on of pip92 by NMDA was mediated by activation of mitogen-activated protein
kinases (MAPKs), such as c-Jun N-terminal kinase (JNK) and p38 kinase, but
not extracellular signal-regulated kinase (ERK) in the mouse hippocampus a
nd immortalized rat hippocampal progenitor cells. This study suggests that
pip92 is likely to play an important role in neuronal cell death induced by
excitotoxic NMDA injury in the CNS.